STRYKER CORP Quarterly Cost of Revenue in USD from Q3 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Stryker Corp quarterly/annual Cost of Revenue history and growth rate from Q3 2017 to Q3 2024.
  • Stryker Corp Cost of Revenue for the quarter ending September 30, 2024 was $1.98B, a 12.9% increase year-over-year.
  • Stryker Corp Cost of Revenue for the twelve months ending September 30, 2024 was $8.01B, a 9.75% increase year-over-year.
  • Stryker Corp annual Cost of Revenue for 2023 was $7.44B, a 8.28% increase from 2022.
  • Stryker Corp annual Cost of Revenue for 2022 was $6.87B, a 11.9% increase from 2021.
  • Stryker Corp annual Cost of Revenue for 2021 was $6.14B, a 16% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $8.01B $1.98B +$226M +12.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $7.78B $2.01B +$191M +10.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $7.59B $1.91B +$148M +8.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $7.44B $2.11B +$146M +7.43% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 $7.29B $1.75B +$54M +3.18% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $7.24B $1.82B +$148M +8.88% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $7.09B $1.76B +$221M +14.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $6.87B $1.97B +$310M +18.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $6.56B $1.7B +$179M +11.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $6.38B $1.67B +$145M +9.53% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $6.24B $1.54B +$97M +6.72% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $6.14B $1.66B +$111M +7.18% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $6.03B $1.52B +$242M +19% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $5.79B $1.52B +$306M +25.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 $5.48B $1.44B +$187M +14.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $5.29B $1.55B +$117M +8.19% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-10
Q3 2020 $5.18B $1.28B +$19M +1.51% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $5.16B $1.22B -$54M -4.25% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 $5.21B $1.26B +$24M +1.95% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 $5.19B $1.43B +$88M +6.57% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-11
Q3 2019 $5.1B $1.26B +$170M +15.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $4.93B $1.27B +$138M +12.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $4.79B $1.23B +$129M +11.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $4.66B $1.34B Oct 1, 2018 Dec 31, 2018 10-K 2021-02-11
Q3 2018 $1.09B +$65M +6.36% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $1.13B Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-26
Q1 2018 $1.1B Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-24
Q3 2017 $1.02B Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.